FolioLanternBeta
SOLVSolventum

Carrie Cox

Director at Solventum, as of May 18, 2026Sold $2.7M of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
16K
shares held after the latest filing, Solventum
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
4
companies filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMay 2026: $2.7M no plan disclosed$2.7MMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Solventum (SOLV)DirectorMay 15, 2024May 18, 2026
Texas Instruments (TXN)DirectorSep 17, 2004May 14, 2026
Cardinal Health (CAH)Former DirectorDec 2, 2009Nov 10, 2022
Merck & Co. (MRK)Former Executive Vice PresidentFeb 25, 2004Nov 4, 2009

Also a director at

Texas Instruments (TXN), Cardinal Health (CAH) (no filing in the last 18 months)

Recent filings

The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.